Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000501821 | SCV000593158 | uncertain significance | not specified | 2016-09-24 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000764902 | SCV000896062 | uncertain significance | Intellectual disability-hypotonia-spasticity-sleep disorder syndrome | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000950190 | SCV001096478 | likely benign | not provided | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Undiagnosed Diseases Network, |
RCV000764902 | SCV002568426 | pathogenic | Intellectual disability-hypotonia-spasticity-sleep disorder syndrome | 2022-06-15 | criteria provided, single submitter | clinical testing | Functional studies proved missense was disruptive (PMID: 31451636). |
Ce |
RCV000950190 | SCV002821510 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | ANK3: BP4 |
Zotz- |
RCV000764902 | SCV004041803 | uncertain significance | Intellectual disability-hypotonia-spasticity-sleep disorder syndrome | 2023-10-09 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004535578 | SCV004740699 | likely benign | ANK3-related disorder | 2022-05-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |